Back
Akebia Therapeutics Stock Price Chart
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now
Buy
62
AKBA
Akebia Therapeutics
Last Price:
$3.64
Seasonality Move:
-6.68%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Favorite AI Energy Stock??
Get the details on #1 AI energy stock here.-
The current trend is moderately bullish and AKBA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akebia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.65 | Sell |
| 20-day SMA: | 3.67 | Sell |
| 50-day SMA: | 3.07 | Buy |
| 200-day SMA: | 2.15 | Buy |
| 8-day EMA: | 3.63 | Sell |
| 20-day EMA: | 3.54 | Buy |
| 50-day EMA: | 3.15 | Buy |
| 200-day EMA: | 2.31 | Buy |
Akebia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 58.46 | Buy |
| Chaikin Money Flow: | 1118180 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.37 - 3.81) | Buy |
| Bollinger Bands (100): | (1.82 - 3.22) | Buy |
Akebia Therapeutics Technical Analysis
| Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akebia Therapeutics Stock
Is Akebia Therapeutics Stock a Buy?
-
Akebia Therapeutics share price is 3.62 while AKBA 8-day simple moving average is 3.65, which is a Sell signal.
-
The stock price of AKBA is 3.62 while Akebia Therapeutics 20-day SMA is 3.67, which makes it a Sell.
-
Akebia Therapeutics 50-day simple moving average is 3.07 while AKBA share price is 3.62, making it a Buy technically.
-
AKBA stock price is 3.62 and Akebia Therapeutics 200-day simple moving average is 2.15, creating a Buy signal.
AKBA Technical Analysis vs Fundamental Analysis
Buy
62
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy or a Sell?
-
Akebia Therapeutics stock is rated a BuyThe current Akebia Therapeutics [AKBA] share price is $3.62. The Score for AKBA is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Akebia Therapeutics Stock Info
Market Cap:
950.7M
Price in USD:
3.62
Share Volume:
1.6M
Akebia Therapeutics 52-Week Range
52-Week High:
4.08
52-Week Low:
0.91
Buy
62
Akebia Therapeutics (AKBA)
is a Buy
Akebia Therapeutics Share Price Forecast
-
What is the Akebia Therapeutics stock price today?The Akebia Therapeutics stock price is 3.62 USD today.
-
Will AKBA stock go up or go down?Akebia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Akebia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akebia Therapeutics is not overvalued.
Is Akebia Therapeutics Stock a Buy?
-
Akebia Therapeutics share price is 3.62 while AKBA 8-day exponential moving average is 3.63, which is a Sell signal.
-
The stock price of AKBA is 3.62 while Akebia Therapeutics 20-day EMA is 3.54, which makes it a Buy.
-
Akebia Therapeutics 50-day exponential moving average is 3.15 while AKBA share price is 3.62, making it a Buy technically.
-
AKBA stock price is 3.62 and Akebia Therapeutics 200-day simple moving average is 2.31, creating a Buy signal.
Fundamental Analysis of Akebia Therapeutics
Is Akebia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.12 per share, an increase this year of $0.21 per share, and an increase next year of $0.32 per share.
Technical Analysis of Akebia Therapeutics
Should I short Akebia Therapeutics stock?
-
AKBA Moving Average Covergence Divergence (MACD) indicator is 0.15, suggesting Akebia Therapeutics is a Buy
-
Akebia Therapeutics Relative Strength Index (RSI) is 58.46, which suggest Akebia Therapeutics is overbought
-
The Bollinger Bands (25) for Akebia Therapeutics is (3.37 - 3.81), which suggest Akebia Therapeutics is a Buy
-
The Bollinger Bands (100) for Akebia Therapeutics is (1.82 - 3.22), which suggest Akebia Therapeutics is a Buy
* Akebia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.